MSWMA
MPLT

Market Street Wealth Management Advisors’s MapLight Therapeutics MPLT Stock Holding History

Market Street Wealth Management Advisors’s Portfolio MPLT Stock Details MPLT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$506K Hold
14,124
– – 0.07% 78
2026
Q1 		$287K Buy
+14,124
New +$253K 0.05% 91

Other funds holding MPLT

S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
MPW
MA Private Wealth San Carlos, California $671M AUM 23.37% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
PWPS
Pinnacle Wealth Planning Services Mansfield, Ohio $1.05B AUM 29.82% 1-Year Est. Return

Market Street Wealth Management Advisors's MPLT Position: Q2 2026 in Review

Market Street Wealth Management Advisors held its MapLight Therapeutics (MPLT) position steady in Q2 2026 at 14,124 shares worth $506K. The position accounts for 0.07% of the portfolio, ranked #78.

Market Street Wealth Management Advisors first reported a position in MPLT in Q1 2026 and has held it in 2 quarters since. 22 funds tracked by Wall St. Rank hold MPLT as of Q2 2026.

  • Market Street Wealth Management Advisors held 14,124 shares of MapLight Therapeutics worth $506K as of Q2 2026.
  • Market Street Wealth Management Advisors left its MapLight Therapeutics share count unchanged in Q2 2026.
  • MapLight Therapeutics made up 0.07% of Market Street Wealth Management Advisors's portfolio in Q2 2026, its #78 holding.
  • Market Street Wealth Management Advisors first reported a position in MapLight Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • 22 funds tracked by Wall St. Rank held MapLight Therapeutics as of Q2 2026.

Based on Market Street Wealth Management Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.